POTENTIATION OF 2CDA ACTIVITY IN CLL BY BRYOSTATIN 1
POTENTIATION OF 2CDA ACTIVITY IN CLL BY BRYOSTATIN 1
批准号:
6350336
负责人:
Ramzi M. Mohammad
金额:
$17.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2003-01-31
关键词:
5' nucleotidase SCID mouse apoptosis bryostatin cell line chemosensitizing agent chlorodeoxyadenosine chronic lymphocytic leukemia clinical research combination chemotherapy cysteine endopeptidases deoxycytidine drug interactions enzyme activity human tissue neoplasm /cancer chemotherapy nonhuman therapy evaluation nucleoside inhibitor protein kinase
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2002-08
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[S. Nabha;R. Mohammad;Mahmoud H. Dandashi;B. Coupaye-Gerard;A. Aboukameel;G. Pettit;A. Al-Katib]
通讯作者:
S. Nabha;R. Mohammad;Mahmoud H. Dandashi;B. Coupaye-Gerard;A. Aboukameel;G. Pettit;A. Al-Katib
Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine.
使用苔藓抑素 1 和氟达拉滨治疗从头氟达拉滨耐药的 CLL 异种移植模型。
DOI:
10.3892/ijo.14.5.945
发表时间:
1999
期刊:
International journal of oncology
影响因子:
5.2
作者:
[Mohammad,RM, Limvarapuss,C, Hamdy,N, Dutcher,BS, Beck,FW, Wall,NR, Al-Katib,AM]
通讯作者:
Al-Katib,AM
Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells.
苔藓抑素 1 诱导 WSU-CLL 细胞中核苷转运蛋白和 2-氯脱氧腺苷流入的调节。
DOI:
10.3892/ijmm.5.4.341
发表时间:
2000
期刊:
International journal of molecular medicine
影响因子:
5.4
作者:
[Beck,FW, Al-Katib,AM, Ahmad,I, Wall,NR, Liu,KZ, Mantsch,HH, Mohammad,RM]
通讯作者:
Mohammad,RM
Preclinical evaluation of 2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]-propionic acid as a modulator of etoposide in human Waldenstrom's macroglobulinemia xenograft model.
2-[4-(7-氯-2-喹喔啉氧基)苯氧基]-丙酸作为人华氏巨球蛋白血症异种移植模型中依托泊苷调节剂的临床前评估。
DOI:
--
发表时间:
2003
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Mensah-Osman,EdithJ, Al-Katib,AyadM, Mohammad,RamziM]
通讯作者:
Mohammad,RamziM
2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]-propionic acid (XK469) inhibition of topoisomerase IIbeta is not sufficient for therapeutic response in human Waldenstrom's macroglobulinemia xenograft model.
2-[4-(7-氯-2-喹喔啉氧基)苯氧基]-丙酸 (XK469) 对拓扑异构酶 IIbeta 的抑制不足以产生人华氏巨球蛋白血症异种移植模型的治疗反应。
DOI:
--
发表时间:
2002
期刊:
Molecular cancer therapeutics
影响因子:
5.7
作者:
[Mensah-Osman,EdithJ, Al-Katib,AyadM, Dandashi,MahmoudH, Mohammad,RamziM]
通讯作者:
Mohammad,RamziM
共 14 条
Differential Network Interrogations of Epithelial to Mesenchymal Transition
-
批准号:8636417
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2013
-
负责人:Ramzi M. Mohammad
-
依托单位:
Differential Network Interrogations of Epithelial to Mesenchymal Transition
-
批准号:8492867
-
项目类别:
-
资助金额:$19.84万
-
财政年份:2013
-
负责人:Ramzi M. Mohammad
-
依托单位:
Development of Small Molecule Crm-1 Inhibitor for Pancreatic Cancer Therapy
-
批准号:8546239
-
项目类别:
-
资助金额:$15.54万
-
财政年份:2012
-
负责人:Ramzi M. Mohammad
-
依托单位:
Development of Small Molecule Crm-1 Inhibitor for Pancreatic Cancer Therapy
-
批准号:8355966
-
项目类别:
-
资助金额:$19.84万
-
财政年份:2012
-
负责人:Ramzi M. Mohammad
-
依托单位:
Specific Targets for Pancreatic Cancer Therapy
-
批准号:7489979
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2007
-
负责人:Ramzi M. Mohammad
-
依托单位:
Specific Targets for Pancreatic Cancer Therapy
-
批准号:7207488
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2007
-
负责人:Ramzi M. Mohammad
-
依托单位:
Specific Targets for Pancreatic Cancer Therapy
-
批准号:7656798
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2007
-
负责人:Ramzi M. Mohammad
-
依托单位:
Specific Targets for Pancreatic Cancer Therapy
-
批准号:7869271
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2007
-
负责人:Ramzi M. Mohammad
-
依托单位:
Specific Targets for Pancreatic Cancer Therapy
-
批准号:8118031
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2007
-
负责人:Ramzi M. Mohammad
-
依托单位:
POTENTIATION OF 2CDA ACTIVITY IN CLL BY BRYOSTATIN 1
-
批准号:2733441
-
项目类别:
-
资助金额:$15.47万
-
财政年份:1999
-
负责人:Ramzi M. Mohammad
-
依托单位:
POTENTIATION OF 2CDA ACTIVITY IN CLL BY BRYOSTATIN 1
-
批准号:6150358
-
项目类别:
-
资助金额:$15.93万
-
财政年份:1999
-
负责人:Ramzi M. Mohammad
-
依托单位:
海外基金